Cleared Traditional

K080750 - BROWNE RAPICIDE GLUTARALDEHYDE INDICATOR

K080750 is the FDA 510(k) clearance for BROWNE RAPICIDE GLUTARALDEHYDE INDICATOR by STERIS Corporation. It is a Class 2 General Hospital device (product code JOJ) cleared through the Traditional 510(k) pathway after a 56-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2008
Decision
56d
Days
Class 2
Risk

K080750 is an FDA 510(k) clearance for the BROWNE RAPICIDE GLUTARALDEHYDE INDICATOR. Classified as Indicator, Physical/chemical Sterilization Process (product code JOJ), Class II - Special Controls.

Submitted by STERIS Corporation (Mentor, US). The FDA issued a Cleared decision on May 12, 2008 after a review of 56 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.2800 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all STERIS Corporation devices

Submission Details

510(k) Number K080750 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 17, 2008
Decision Date May 12, 2008
Days to Decision 56 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 129d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JOJ Indicator, Physical/chemical Sterilization Process
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.2800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - JOJ Indicator, Physical/chemical Sterilization Process

All 114
Devices cleared under the same product code (JOJ) and FDA review panel - the closest regulatory comparables to K080750.
VERIFY 275F GRAVITY INDICATORS
K083643 · STERIS Corporation · Aug 2009
STERIS RESERT XL TEST STRIP
K081600 · STERIS Corporation · Aug 2008
BROWNE OPA TEST STRIP
K081427 · STERIS Corporation · Jun 2008
VERIFY CHALLENGE PACKS - VERSION 2
K073683 · STERIS Corporation · Jan 2008
VERIFY V-PRO CHEMICAL INDICATOR, VERSIONS 1 AND 2
K072510 · STERIS Corporation · Dec 2007
VERIFY 275 DEGREE F. 3-10 INDICATOR
K071895 · STERIS Corporation · Nov 2007